[1] Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, et al. An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR?Dependent Pathway. Cancer Discovery September 15, 2011 ; Published OnlineFirst September 15, 2011; doi:10.1158/2159-8290.CD-11-0102
[2] Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, Gini B, et al. Oncogenic EGFR signaling activates an mTORC2-NF-?B pathway that promotes chemotherapy resistance. Cancer Discovery September 13, 2011 CD-11-0124; Published OnlineFirst September 13, 2011; doi:10.1158/2159-8290.CD-11-0124
Home Guo D, Reinitz F, Youssef M, Hong C
